Physician profile
Brian N Kirschner
NPI 1205872058
$15,373.68
in general payments reported to CMS, 2019-2025
50 companies · $1,512 in 2025
The $1,512 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,995 · 2020: $787 · 2021: $3,498 · 2022: $2,252 · 2023: $1,718 · 2024: $1,612 · 2025: $1,512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,520 · Consulting Fee: $300 · Education: $22.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,520.15 |
| Consulting Fee | $300.00 |
| Education | $22.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $2,189.07 | 2019-2025 | Rytary, Crexont |
| Teva Pharmaceuticals USA, INC. | $1,337.12 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Novartis Pharmaceuticals Corporation | $1,144.77 | 2019-2025 | |
| Abbvie INC. | $1,101.97 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $1,020.00 | 2021 | |
| Biogen, INC. | $972.49 | 2019-2025 | Tysabri |
| Banner Life Sciences, LLC | $900.00 | 2021 | |
| Neurocrine Biosciences, INC. | $817.22 | 2019-2025 | Ingrezza, Ongentys |
| Emd Serono, INC. | $766.22 | 2019-2023 | Mavenclad |
| Acadia Pharmaceuticals INC | $445.37 | 2019-2025 | Nuplazid |
| Celgene Corporation | $368.61 | 2022-2025 | Zeposia |
| Amgen INC. | $329.42 | 2019-2022 | |
| Genzyme Corporation | $304.76 | 2021-2025 | |
| Genentech USA, INC. | $303.77 | 2019-2025 | Ocrevus Zunovo, Ocrevus, Enspryng |
| Allergan, INC. | $297.28 | 2019-2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Kirschner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.